Post Tagged with: "Novartis"


Novartis Announces CEO Joseph Jimenez to Retire from in 2018

Novartis Announces CEO Joseph Jimenez to Retire in 2018

Vasant Narasimhan appointed CEO, effective Feb. 1, 2018.

Novartis invests in next generation therapies to reduce cardiovascular risk in patients with underlying lipid disorders

Novartis Appoints Bertrand Bodson as Chief Digital Officer

New leader to drive the digital transformation Novartis has embarked upon.

Novartis: Sandoz Expands Partnership with World Child Cancer

Novartis: Sandoz Expands Partnership with World Child Cancer

Partnership to help children access treatment in four developing countries.

Google Engineer’s Anti-Diversity Memo Displays Company’s Misogynist Culture

Google Engineer’s Anti-Diversity Memo Displays Company’s Misogynist Culture

Top leaders at the company demonstrated their own worst practices by hiding behind a statement from their brand new head of diversity, who has only been on the job for a couple of weeks.

Novartis: A Researcher Seeks the Roots of Plants’ Healing Power

Novartis: A Researcher Seeks the Roots of Plants’ Healing Power

Edmund Ekuadzi received support from Novartis when he completed an internship in 2012 through the company’s Next Generation Scientist Program.

Novartis: People are Happier, More satisfied with Their Lives After Cataract Surgery

Novartis: People are Happier, More Satisfied with Their Lives After Cataract Surgery

Newly released survey findings shed light on the daily challenges associated with cataracts and the emotional benefits of improved vision after surgery.

Novartis: Helping Syrian Refugees Manage Chronic Diseases

Novartis: Helping Syrian Refugees Manage Chronic Diseases

Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Novartis Invites Scrutiny of Effort to Improve Access to Medicine

Novartis Invites Scrutiny of Effort to Improve Access to Medicine

Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success

Novartis: Striving to Vanquish Leukemia

Novartis: Striving to Vanquish Leukemia

A combination of two compounds shows promise in the lab.

From left: Sherry, Shelley and Christi.

More Moments More Memories Foundation Launched

The Foundation helps ease financial burdens for individuals with cancer as they travel to clinical trials.

Novartis invests in next generation therapies to reduce cardiovascular risk in patients with underlying lipid disorders

Novartis Shareholders Approve All Resolutions Proposed by Board of Directors

Dr. Joerg Reinhardt confirmed by shareholders as chairman of the Novartis Board of Directors as well as all other members who have stood for re-election.

Novartis: Medical Researchers Using New Tools to Turn Science Fiction into Fact

Novartis: Medical Researchers Using New Tools to Turn Science Fiction into Fact

Jay Bradner, president of the Novartis Institutes for BioMedical Research (NIBR) and Chief Medical Officer Vas Narasimhan, also head of Global Drug Development, share their outlook for innovation in 2017.

Novartis' Women in Science: Virginia Lazala

Novartis’ Women in Science: Virginia Lazala

"Do not let anyone tell you that you can’t succeed in science because you’re a woman or a girl," said Lazala.

Novartis Event Explores Response to Chronic Illness in Poor Countries

Novartis Event Explores Response to Chronic Illness in Poor Countries

Health experts from around the world met November 29 to discuss ways to tackle an emerging crisis.

Novartis Next Generation of Scientists

Nurturing the Next Generation of Scientists

Novartis internships help build research capabilities in developing countries.

Novartis Announces CEO Joseph Jimenez to Retire from in 2018

Novartis Convenes Experts to Discuss New Technologies in Healthcare at Novartis International BioCamp

Interactive program brings 60 top university students from 18 countries and territories to Novartis headquarters in Switzerland.

Novartis’ Steven Baert: Diversity of Experience Leads to Stronger Business Decisions

The global background of this Belgium native has allowed him to see firsthand that diversity leads to innovation, engagement and stronger decision making.